Auger processes in the 21st century

International Journal of Radiation Biology

Volumn 84, Issue 12, 2008, Pages 959-975

  Howell, Roger W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Auger emitters; DNA damage; Radiation chemistry; Radiation physics; Radionuclides; Radiotherapy

Indexed keywords

AUGER ELECTRON SPECTROSCOPY; CONFERENCE PAPER; DNA DAMAGE; IONIZING RADIATION; MEDICAL RESEARCH; PRIORITY JOURNAL; RADIATION PHYSICS; RADIOBIOLOGY; RADIOCHEMISTRY; UNITED STATES;

CELL SURVIVAL; DNA DAMAGE; ELECTRONS; IODINE RADIOISOTOPES; NEOPLASMS; NUCLEAR MEDICINE; RADIOACTIVITY;

EID: 57349122162     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000802395527     Document Type: Conference Paper

References (151)

1. Adam JF, Joubert A, Biston MC, Charvet AM, Peoc'h, M, Le Bas JF, Balosso J, Esteve F, Elleaume H. 2006. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. International Journal of Radiation Oncology Biology Physics 64:603-11.
2. Adelstein SJ. 1992. Biophysical apsects of Auger processes: A review of the literature 1987-1991. In: Howell RW, Narra VR, Sastry KSR, Rao DV, editors. Woodbury, NY: American Institute of Physics (http://www.aapm.org/pubs/ books/PROC_8.pdf). pp 1-13.
3. Auger P. 1925. Sur les rayons β secondaires produit dans un gaz par des rayons X. Comptes Rendues Hehdomadaires des Seances de L'Academie des Sciences 180:65-68.
4. Azure MT, Sastry KSR, Archer RD, Howell RW, Rao DV. 1992. Microscale synthesis of carboplatin labeled with the Auger emitter Pt-193m: Radiotoxicity versus chemotoxicity of the antitumor drug in mammalian cells. In: Howell RW, Narra VR, Sastry KSR, Rao DV, editors. Woodbury, NY: American Institute of Physics (http://www.aapm.org/pubs/books/default.asp). pp 336-351.
5. 125I-Hoechst. Radiation Research 166:333-344.
6. Bapat K, Chintalwar GJ, Pandey U, Thakur VS, Sarma HD, Samuel G, Pillai MR, Chattopadhyay S, Venkatesh M. 2005. Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Applied Radiation and Isotopes 62:389-393.
7. Barth S, Joshi S, Marburger S, Ulrich V, Lindblad A, Ohrwall G, Bjorneholm O, Hergenhahn U. 2005. Observation of resonant interatomic coulombic decay in Ne clusters. Journal of Chemical Physics 122:241102.
8. Baverstock KF, Charton DE, editors. 1988. DNA damage by Auger emitters. London: Taylor & Francis; 1988.
9. Baverstock KF, Cundall RB. 1988. Solitons and energy transfer in DNA. Nature 332:312-313.
10. Bé MM, Chiste V, Dulieu C. 2006. Detailed calculation of K- and L-Auger electron emission intensities following radioactive disintegration. Applied Radiation and Isotopes 64:1435-1439.
11. Biston MC, Joubert A, Adam JF, Elleaume H, Bohic S, Charvet AM, Esteve F, Foray N, Balosso J. 2004. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Research 64:2317-2323.
12. Boswell CA, Brechbiel MW. 2005. Auger electrons: Lethal, low energy, and coming soon to a tumor cell nucleus near you. Journal of Nuclear Medicine 46:1946-1947.
13. Boyd M, Ross SC, Dorrens J, Fullerton NE, Tan KW, Zalutsky MR, Mairs RJ. 2006. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. Journal of Nuclear Medicine 47:1007-1015.
14. Bradley EW, Chan PC, Adelstein SJ. 1975. The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiation Research 64:555-563.
15. 125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts. International Journal of Cancer 110:145-149.
16. Buchegger F, Perillo-Adamer F, Dupertuis YM, Delaloye AB. 2006. Auger radiation targeted into DNA: A therapy perspective. European Journal of Nuclear Medicine Molecular Imaging 33:1352-1363.
17. 111In-labelled somatostatin analogues in a rat tumour model: Somatostatin receptor status and effects of peptide receptor radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging 32:1288-1295.
18. 125I. International Journal of Radiation Biology 82:211-220.
19. Cederbaum LS, Zobeley J, Tarantelli F. 1997. Giant intermolecular decay and fragmentation of clusters. Physical Review Letters 79:4778.
20. Charlton DE, Booz J. 1981. A Monte Carlo treatment of the decay of I-125. Radiation Research 87:10-23.
21. Chen K, Wang K, Kirichian AM, Al Aowad AF, Iyer LK, Adelstein SJ, Kassis AI. 2006a. In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy. Molecular Cancer Therapeutics 5:3001-3013.
22. 111In in human myeloid leukemia cells. Journal of Nuclear Medicine 47:827-836.
23. Corde S, Joubert A, Adam JF, Charvet AM, Le Bas JF, Esteve F, Elleaume H, Balosso J. 2004. Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. British Journal of Cancer 91:544-551.
24. 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells. Nuclear Medicine and Biology 34:37-46.
25. Datta K, Jaruga P, Dizdaroglu M, Neumann RD, Winters TA. 2006. Molecular analysis of base damage clustering associated with a site-specific radiation-induced DNA double-strand break. Radiation Research 166:767-781.
26. Datta K, Neumann RD, Winters TA. 2005a. Characterization of complex apurinic/apyrimidinic-site clustering associated with an authentic site-specific radiation-induced DNA double-strand break. Proceedings of the National Academy of Sciences of the USA 102:10569-10574.
27. 125I-induced DNA double-strand break: Implications for repair. International Journal of Radiation Biology 81:13-21.
28. 111)In- DTPA]octreotide. Journal of Nuclear Medicine 45:1168-1171.
29. Dingli D, Peng KW, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris JC, Russell SJ. 2005. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochemical Biophysical Research Communications 337:22-29.
30. 125I decay. Radiation Protection Dosimetry 122:136-140.
31. 125I induces more than one double-strand break per decay in mammalian cells. Radiation Research 163:369-373.
32. Emfietzoglou D, Nikjoo H. 2005. The effect of model approximations on single-collision distributions of low-energy electrons in liquid water. Radiation Research 163:98-111.
33. Emfietzoglou D, Nikjoo H. 2007. Accurate electron inelastic cross sections and stopping powers for liquid water over the 0.1-10 keV range based on an improved dielectric description of the Bethe surface. Radiation Research 167:110-120.
34. Ertl HH, Feinendegen LE, Heiniger HJ. 1970. Iodine-125, a tracer in cell biology: Physical properties and biological aspects. Physics of Medicine and Biology 15:447-456.
35. Fairchild RG, Bond VP. 1984. Photon activation therapy. Strahlentherapie 160:758-763.
36. Fairchild RG, Brill AB, Ettinger KV. 1982. Radiation enhancement with iodinated deoxyuridine. Investigative Radiology 17:407-416.
37. Feinendegen LE. 1975. Biological damage from the Auger effect, possible benefits. Radiation Environmental Biophysics 12:85-99.
38. 2. Journal of Chemical Physics 123:224306.
39. Foulon CF, Zhang YZ, Adelstein SJ, Kassis AI. 1995. Instantaneous preparation of radiolabeled 5-iodo-2′-deoxyuridine. Applied Radiation and Isotopes 46:1039-1046.
40. Fujii K, Akamatsu K, Yokoya A. 2004. Ion desorption from DNA components irradiated with 0.5 keV ultrasoft X-ray photons. Radiation Research 161:435-441.
41. 125I]histamine complex. Preliminary report. Nuclear Medicine Review. Central and Eastern Europe 7:113-116.
42. Ghirmai S, Mume E, Tolmachev V, Sjoberg S. 2005. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives. Carbohydrate Research 340:15-24.
43. Ginj M, Chen J, Walter MA, Eltschinger V, Reubi JC, Maecke HR. 2005a. Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. Clinical Cancer Research 11:1136-1145.
44. Ginj M, Hinni K, Tschumi S, Schulz S, Maecke HR. 2005b. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using Auger electron emitters. Journal of Nuclear Medicine 46:2097-2103.
45. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD Cellular S values: Self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments, Reston, VA: Society of Nuclear Medicine.
46. 67Ga after intravenous administration. International Journal of Nuclear Medicine and Biology 8:211-212.
47. +. Bioconjugate Chemistry 16:582-587.
48. 99mTc complexes with DNA-binding ligands. ChemBioChem 6:414-421.
49. 123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage. Nuclear Medicine Communications 25:1125-1130.
50. 125I-radioprobing. Nucleic Acids Research 32: 5359-5367.
51. 111In-labeled peptide nucleic acids. European Journal of Nuclear Medicine and Molecular Imaging 31:837-845.
52. Hikosaka Y, Aoto T, Lablanquie P, Penent F, Shigemasa E, Ito K. 2006. Experimental investigation of core-valence double photoionization. Physical Review Letters 97:053003.
53. Hikosaka Y, Lablanquie P, Penent F, Kaneyasu T, Shigemasa E, Eland JH, Aoto T, Ito K. 2007. Double photoionization into double core-hole states in Xe. Physical Review Letters 98:183002.
54. 192Ir. Applied Radiation and Isotopes 63:93-98.
55. Hofer KG. 1992. Closing address: Biophysical aspects of Auger processes. In: Howell RW, Narra VR, Sastry KSR, Rao DV, editors. Woodbury, NY: American Institute of Physics (http:// www.aapm.org/pubs/books/PROC_8.pdf). pp 403-412.
56. Hofer KG. 1996. Biophysical aspects of Auger processes - a review. Acta Oncologica 35:789-796.
57. Hofer KG. 2000. Biophysical aspects of Auger processes. Acta Oncologica 39:651-657.
58. Hofer KG, Hughes WL. 1971. Radiotoxicity of intranuclear tritium, iodine-125 and iodine-131. Radiation Research 47:94-109.
59. Horgan J. 1996. The end of science: Facing the limits of knowledge in the twilight of the scientific age. Reading, MA: Addison-Wesley.
60. Hosain F, Hosain P, Spencer RP. 1978. Testicular imaging with thallium-201 and comparison with other radionuclides. Journal of Nuclear Medicine 19:720-720.
61. Hou DY, Hoch H, Johnston GS, Tsou KC, Jones AE, Farkas RJ, Miller EE, Larson SM. 1985. A new In-111 bleomycin complex for combined radiotherapy and chemotherapy. Journal of Surgical Oncology 29:91-98.
62. Howell RW. 1992. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 19:1371-1383.
63. 195mPt labeled trans-platinum(II) in mammalian cells. Radiation Research 140:55-62.
64. Howell RW, Narra VR, Rao DV, Sastry KSR. 1990. Radiobiological effects of intracellular polonium-210 alpha emissions: A comparison with Auger-emitters. Radiation Protection Dosimetry 31:325-328.
65. Howell RW, Narra VR, Sastry KSR, Rao DV, editors. 1992. Biophysical aspects of Auger processes. American Institute of Physics (http://www.aapm.org/pubs/books/PROC_8.pdf), New York.
66. Howell RW, Sastry KSR, Hill HZ, Rao DV. 1986. Cis-platinum-193m: Its microdosimetry and potential for chemo-Auger combination therapy of cancer. In: Schlafke-Stelson AT, Watson EE, editors. Springfield, VA: National Technical Information Service. pp 493-513.
67. 123)I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1). European Journal of Nuclear Medicine and Molecular Imaging 34:368-377.
68. 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy. Nuclear Medicine and Biology 33:773-783.
69. Jaaskela-Saari HA, Grenman R, Ramsay HA, Tarkkanen J, Paavonen T, Kairemo KJ. 2005. Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice. Cancer Biotherapy and Radiopharmaceuticals 20:426-435.
70. Kassis AI. 2004. The amazing world of Auger electrons. International Journal of Radiation Biology 80:789-803.
71. Kassis AI, Adelstein SJ, Haydock C, Sastry KSR. 1980. Radiotoxicity of Se-75 and S-35: Theory and application to a cellular model. Radiation Research 84:407-425.
72. 125I]iodo-2′-deoxyuridine in mammalian cells following treatment with 5-fluoro-2′-deoxyuridine. Journal Nuclear Biology and Medicine 35:167-173.
73. Kassis AI, Harapanhalli RS, Adelstein SJ. 1999. Comparison of strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125. Radiation Research 151:167-176.
74. Kato HS, Furukawa M, Kawai M, Taniguchi M, Kawai T, Hatsui T, Kosugi N. 2004. Electronic structure of bases in DNA duplexes characterized by resonant photoemission spectroscopy near the Fermi level. Physical Review Letters 93:086403.
75. Kawai J. 2005. Radiative Auger effect and extended X-ray emission fine structure (EXEFS). Analytical Sciences 21:733-735.
76. Kawai J, Ohta M, Konishi T. 2005. Chemical effects in high-resolution nickel Kα X-ray fluorescence spectra. Analytical Sciences 21:865-868.
77. Kienberger R, Goulielmakis E, Uiberacker M, Baltuska A, Yakovlev V, Bammer F, Scrinzi A, Westerwalbesloh T, Kleineberg U, Heinzmann U, Drescher M, Krausz F. 2004. Atomic transient recorder. Nature 427:817-821.
78. Kishikawa H, Wang K, Adelstein SJ, Kassis AI. 2006. Inhibitory and stimulatory bystander effects are differentially induced by Iodine-125 and Iodine-123. Radiation Research 165:688-694.
79. Knapp FF, Mirzadeh H, Beets AL, Du M. 2005. Production of therapeutic isotopes in the ORNL High Flux Isotope Reactor (HIFR) for applications in nuclear medicine, oncology, and interventional cardiology. Journal of Radiochemical and Nuclear Chemistry 263:503-509.
80. Konijnenberg M, Melis M, Valkema R, Krenning E, de Jong M. 2007. Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy. Journal of Nuclear Medicine 48:134-142.
81. 125I-DOTA-TATE. Applied Radiation and Isotopes 65:687-690.
82. Kou J, Mori T, Kumar SV, Haruyama Y, Kubozono Y, Mitsuke K. 2004. Double photoionization of C(60) and C(70) in the valence region. Journal of Chemical Physics 120:6005-6009.
83. (99m)Tc. International Journal of Radiation Biology 80:875-880.
84. 65Zn in two human cell lines. Radiation and Environmental Biophysics 43:15-22.
85. Kugeler O, Prumper G, Hentges R, Viefhaus J, Rolles D, Becker U, Marburger S, Hergenhahn U. 2004. Intramolecular electron scattering and electron transfer following autoionization in dissociating molecules. Physical Review Letters 93:033002.
86. Kullberg EB, Stenerlow B, Ghirmai S, Lundqvist H, Malmstrom PU, Orlova A, Tolmachev V, Gedda L. 2005. An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assay. International Journal of Oncology 27:1355-1360.
87. Kümmerle EA, Pomplun E. 2005. A computer-generated supercoiled model of the pUC19 plasmid. European Biophysics Journal 34:13-18.
88. Laughton CA, Grindon C, Girard P, Nikjoo H. 2004. The mysteries of telomere structure and recognition: could radioprobing help? International Journal of Radiation Biology 80:805-811.
89. 125I decays in a synthetic oligodeoxynucleotide using charge transfer theory. Radiation Protection Dosimetry 122:89-94.
90. 125I decay in a synthetic oligodeoxynucleotide with normal and distorted geometry and the role of radiation and non-radiation actions. Radiation and Environmental Biophysics 43:23-33.
91. Limouris GS, Dimitropoulos N, Kontogeorgakos D, Papanikolos G, Koutoulidis V, Hatzioannou A, Mourikis D, Lyra M, Dimitriou P, Stravaka A, Vlahos L. 2005. Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings. Cancer Biotherapy and Radiopharmaceuticals 20:215-217.
92. Lobachevsky PN, Karagiannis TC, Martin RF. 2004. Plasmid DNA breakage by decay of DNA-associated Auger electron emitters: Approaches to analysis of experimental data. Radiation Research 162:84-95.
93. 123I-iodo-Hoechst 33258 and plasmid DNA. Radiation Research 164:766-773.
94. Malonda AG, Carles AG, Garcia G. 2006. Mean values of the LMM Auger transition in a KLM model. Applied Radiation and Isotopes 64:1485-1491.
95. 3 integrins in tumor angiogenesis. Bioconjugate Chemistry 15:988-996.
96. 1 und seine deutung. Zeitschrift für Physik 17:54-66.
97. Melero Garcia E, Kivimaki A, Pettersson LG, Alvarez Ruiz J, Coreno M, de Simone M, Richter R, Prince KC. 2006. Fluorescence emission of excited hydrogen atoms after core excitation of water vapor. Physical Review Letters 96:063003.
98. 111In-labeled antibodies to HER-2. Molecular Cancer Therapy 4:927-937.
99. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo. Nuclear Medicine and Biology 32:269-278.
100. Michel RB, Castillo ME, Andrews PM, Mattes MJ. 2004. In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons. Clinical Cancer Research 10:5957-5966.
101. Michel RB, Rosario AV, Andrews PM, Goldenberg DM, Mattes MJ. 2005c. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons. Clinical Cancer Research 11:777-786.
102. 99mTc radiopharmaceuticals. Medical Physics 21:1921-1926.
103. Neti PVSV, Howell RW. 2006. Log normally distributed cellular uptake of radioactivity: Implications for biological responses to radiopharmaceuticals. Journal of Nuclear Medicine 47:1049-1058.
104. 201Tl in human testes. Journal of Nuclear Medicine 45:138-146.
105. Nikjoo H, Girard P, Charlton DE, Hofer KG, Laughton CA. 2006. Auger electrons - a nanoprobe for structural, molecular and cellular processes. Radiation Protection Dosimetry 122:72-79.
106. 64Cu-ATSM as a radiotherapy agent. Nuclear Medicine and Biology 32:21-28.
107. Ohrwall G, Fink RF, Tchaplyguine M, Ojamae L, Lundwall M, Marinho RR, Naves de Brito A, Sorensen SL, Gisselbrecht M, Feifel R, Rander T, Lindblad A, Schulz J, Saethre LJ, Martensson N, Svensson S, Bjorneholm O. 2005. The electronic structure of free water clusters probed by Auger electron spectroscopy. Journal of Chemical Physics 123:054310.
108. 125I labeled oligonucleotides. Nucleic Acids Research 22:4979-4982.
109. Panyutin IG, Neumann RD. 2005. The potential for gene-targeted radiation therapy of cancers. Trends in Biotechnology 23:492-496.
110. Panyutin IG, Winters TA, Feinendegen LE, Neumann RD. 2000. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. Quarterly Journal of Nuclear Medicine 44:256-267.
111. 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei. Annals of the New York Academy of Sciences 1058:140-150.
112. 125Iiododeoxyuridine. European Journal of Nuclear Medicine and Molecular Imaging 33:613-620.
113. Pernpointner M, Knecht S. 2005. The influence of relativistic effects on the ionization spectra of the alkali iodides. Chemical Physics Letters 410:423-429.
114. Pernpointner M, Knecht S, Cederbaum LS. 2006. Ionization spectra and electronic decay in small iodide clusters: fully relativistic results. Journal of Chemical Physics 125:34309.
115. Peudon A, Edel S, Terrissol M. 2006. Molecular basic data calculation for radiation transport in chromatin. Radiation Protection Dosimetry 122:128-135.
116. Pomplun E, Booz J, Charlton DE. 1987. AMonte Carlo simulation of Auger cascades. Radiation Research 111:533-552.
117. 125IUdR? International Journal of Radiation Biology 80:855-860.
118. 99mTc. Radiation Protection Dosimetry 122:80-81.
119. Pospisil P, Wang K, Al Aowad AF, Iyer LK, Adelstein SJ, Kassis AI. 2007. Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors. Cancer Research 67:2197-2205.
120. Rao DV, Govelitz GF, Sastry KSR. 1983. Radiotoxicity of thallium-201 in mouse testes: Inadequacy of conventional dosimetry. Journal of Nuclear Medicine 24:145-153.
121. Rao DV, Narra VR, Govelitz GF, Lanka VK, Howell RW, Sastry KSR. 1990. In vivo effects of 5.3 MeV alpha particles from Po-210 in mouse testes: Comparison with internal Auger emitters. Radiation Protection Dosimetry 31:329-332.
122. Rao DV, Sastry KSR, Grimmond HE, Howell RW, Govelitz GF, Lanka VK, Mylavarapu VB. 1988. Cytotoxicity of some indium radiopharmaceuticals in mouse testes. Journal of Nuclear Medicine 29:375-384.
123. Rao DV, Shepstone B, Wilkins HG, Howell RW. 1995. Testicular kinetics and dosimetry of Tl-201 in humans. Journal of Nuclear Medicine 36:607-609.
124. 111In-DTPA-human epidermal growth factor: An Auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. Journal of Nuclear Medicine 47:1023-1031.
125. 111In for radiotherapeutic applications. Journal of Nuclear Medicine 45:701-708.
126. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in Doxorubicin-, β-, or γ-radiation-resistant cell lines. Journal of Nuclear Medicine 48:1000-1007.
127. Rousseau J, Boudou C, Esteve F, Elleaume H. 2007. Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy. International Journal of Radiation Oncology Biology Physics 68:943-951.
128. 125I: A review. Report No. 1 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 19:1361-1370.
129. Sastry KSR, Rao DV. 1984. Dosimetry of low energy electrons. In: Rao DV, Chandra R, Graham M, editors. New York: American Institute of Physics. pp 169-208.
130. 125I]iodo-2′-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy. Nuclear Medicine Communications 25:461-468.
131. 131)I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. European Journal of Nuclear Medicine Molecular Imaging 34:638-650.
132. Sech CL, Takakura K, Saint-Marc C, Frohlich H, Charlier M, Usami N, Kobayashi K. 2000. Strand break induction by photoabsorption in DNA-bound molecules. Radiation Research 153:454-458.
133. 125I]iodo-2′-deoxyuridine in metastatic lung cancer: Radiopharmaceutical formulation affects targeting. Journal of Nuclear Medicine 46:800-806.
134. Sokolov MV, Smirnova NA, Camerini-Otero RD, Neumann RD, Panyutin IG. 2006. Microarray analysis of differentially expressed genes after exposure of normal human fibroblasts to ionizing radiation from an external source and from DNA-incorporated iodine-125 radionuclide. Gene 382:47-56.
135. 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: A pilot study. Nuclear Medicine Communications 25:683-690.
136. Takahashi O, Odelius M, Nordlund D, Nilsson A, Bluhm H, Pettersson LG. 2006. Auger decay calculations with core-hole excited-state molecular-dynamics simulations of water. Journal of Chemical Physics 124:64307.
137. Tanis JA, Landers AL, Pole DJ, Alnaser AS, Hossain S, Kirchner T. 2004. Evidence for Pauli exchange leading to excited-state enhancement in electron transfer. Physical Review Letters 92:133201.
138. Uiberacker M, Uphues T, Schultze M, Verhoef AJ, Yakovlev V, Kling MF, Rauschenberger J, Kabachnik NM, Schroder H, Lezius M, Kompa KL, Muller HG, Vrakking MJ, Hendel S, Kleineberg U, Heinzmann U, Drescher M, Krausz F. 2007. Attosecond real-time observation of electron tunnelling in atoms. Nature 446:627-632.
139. Urashima T, Nagasawa H, Wang K, Adelstein SJ, Little JB, Kassis AI. 2006. Induction of apoptosis in human tumor cells after exposure to Auger electrons: Comparison with gamma-ray exposure. Nuclear Medicine and Biology 33:1055-1063.
140. 2+ ion irradiation of DNA loaded with platinum-containing molecules. International Journal of Radiation Biology 81:515-522.
141. Uusijärvi H, Bernhardt P, Ericsson T, Forssell-Aronsson E. 2006. Dosimetric characterization of radionuclides for systemic tumor therapy: Influence of particle range, photon emission, and subcellular distribution. Medical Physics 33:3260-3269.
142. Van Houten B, Woshner V, Santos JH. 2006. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amsterdam) 5:145-152.
143. 125I]iodorotenol. Nuclear Medicine and Biology 34:109-116.
144. Viefhaus J, Cvejanovic S, Langer B, Lischke T, Prumper G, Rolles D, Golovin AV, Grum-Grzhimailo AN, Kabachnik NM, Becker U. 2004. Energy and angular distributions of electrons emitted by direct double auger decay. Physical Review Letters 92:083001.
145. Villani C, Tarantelli F. 2004. Double ionization of fluorinated benzenes: Hole localization and delocalization effects. Journal of Chemical Physics 120:1775-1791.
146. Wang K, Kirichian AM, Aowad AF, Adelstein SJ, Kassis AI. 2007. Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative. Bioconjugate Chemistry 18:754-764.
147. 111In-labeled N-myc antisense oligonucleotides. Journal of Nuclear Medicine 47:1670-1677.
148. Wright HA, Hamm RN, Turner JE, Howell RW, Rao DV, Sastry KSR. 1990. Calculations of physical and chemical reactions with DNA in aqueous solution from Auger cascades. Radiation Protection Dosimetry 31:59-62.
149. 111In. Applied Radiation and Isotopes 62:451-456.
150. Yasui LS, Chen K, Wang K, Jones TP, Caldwell J, Guse D, Kassis AI. 2007. Using Hoechst 33342 to target radioactivity to the cell nucleus. Radiation Research 167:167-175.
151. Yasui LS, Hofer KG. 1986. Role of mitochondrial DNA in cell death induced by I-125 decay. International Journal of Radiation Biology 49:601-610.